Skip to main content
. 2016 Sep 1;11(9):e0162074. doi: 10.1371/journal.pone.0162074

Table 3. Age and sex adjusted odds ratio (OR) and adjusted hazard ratio (HR) of mortality and cardiovascular disease CVD) hospitalization by duration of retrospective observation among patients with newly diagnosed hypertension.

Mortality CVD
Chronic conditions OR of 1 year mortality HR of mortality OR of 1 year mortality HR of mortality
  6M 1yr 2yrs 3yrs 6M 1yr 2yrs 3yrs 6M 1yr 2yrs 3yrs 6M 1yr 2yrs 3yrs
Claims only
Myocardial infarction 2.17  2.04 1.86 1.77 1.34 1.31 1.28 1.28 2.09 1.95 1.98 1.84 1.68 1.53 1.52 1.48
Congestive heart failure 3.45 3.23 3.07 2.98 2.30 2.25 2.20 2.16 2.31 2.30 2.30 2.22 2.43 2.37 2.37 2.37
Peripheral vascular disease 1.59 1.53 1.47 1.43 1.40 1.40 1.38 1.36 1.76 1.65 1.64 1.62 2.23 2.22 2.14 2.15
Cerebrovascular disease 3.17 2.92 2.66 2.46 1.77 1.71 1.62 1.58 1.70 1.69 1.69 1.65 1.77 1.77 1.76 1.72
Dementia 3.78 3.72 3.64 3.55 2.80 2.77 2.73 2.68 1.24 1.19 1.20 1.21 1.47 1.42 1.42 1.43
Chronic pulmonary disease 1.99 1.79 1.62 1.50 1.65 1.56 1.45 1.38 1.47 1.43 1.41 1.35 1.89 1.81 1.74 1.71
Connective tissue disease- rheumatic disease 1.38 1.27 1.17 1.12 1.31 1.25 1.21 1.19 1.45 1.40 1.39 1.35 1.63 1.60 1.55 1.54
Peptic ulcer disease 1.40 1.34 1.23 1.15 1.17 1.17 1.13 1.07 1.25 1.25 1.26 1.25 1.38 1.34 1.28 1.24
Diabetes without complication 1.43 1.43 1.38 1.38 1.51 1.49 1.44 1.43 2.19 2.14 2.09 2.11 2.29 2.23 2.16 2.17
Diabetes with complication 1.63 1.46 1.45 1.52 1.57 1.53 1.56 1.58 3.75 3.32 3.27 3.22 3.90 3.72 3.55 3.45
Paraplegia and hemiplegia 1.59 1.59 1.61 1.55 1.43 1.47 1.51 1.47 1.31 1.34 1.30 1.50 1.27 1.27 1.27 1.22
Renal disease 4.19 3.97 3.78 3.62 2.40 2.31 2.22 2.19 1.37 1.32 1.29 1.26 2.76 2.64 2.58 2.55
Mild liver disease 4.38 3.93 3.24 2.96 2.89 2.74 2.34 2.23 1.89 1.78 1.65 1.64 2.21 2.03 1.85 1.81
Moderate and severe liver disease 4.96 4.09 3.85 3.83 2.46 2.40 2.31 2.47 1.97 2.05 2.15 1.98 3.15 3.06 3.10 2.75
Cancer 5.85 5.01 4.19 3.78 2.47 2.26 2.04 1.96 1.16 1.13 1.11 1.11 1.34 1.28 1.23 1.22
Metastatic carcinoma 8.46 7.92 7.69 7.21 3.39 3.40 3.18 3.08 1.68 1.64 1.63 1.67 1.68 1.65 1.57 1.55
AIDS/HIV 3.47 3.74 2.69 2.28 2.86 2.79 1.99 1.80 2.45 2.10 2.10 2.09 2.64 2.23 2.15 2.04
Hospital abstract data only
Myocardial infarction 1.66 1.61 1.56 1.52 1.22 1.21 1.20 1.19 1.92 2.01 2.02 2.06 1.28 1.30 1.33 1.42
Congestive heart failure 3.25 3.12 2.98 2.96 2.05 2.00 1.97 1.98 2.37 2.44 2.42 2.31 1.45 1.42 1.34 1.55
Peripheral vascular disease 1.57 1.55 1.55 1.50 1.30 1.29 1.30 1.30 1.60 1.69 1.69 1.65 1.71 1.75 1.77 1.81
Cerebrovascular disease 3.01 2.88 2.72 2.64 1.60 1.57 1.54 1.53 1.71 1.70 1.70 1.68 1.40 1.43 1.47 1.51
Dementia 3.02 3.02 3.08 3.06 2.15 2.16 2.23 2.22 1.09 1.15 1.18 1.18 1.05 1.09 1.11 1.14
Chronic pulmonary disease 2.10 2.05 1.98 1.95 1.69 1.69 1.67 1.65 1.45 1.41 1.38 1.33 1.57 1.54 1.49 1.46
Connective tissue disease- rheumatic disease 2.24 2.18 2.04 1.92 1.72 1.71 1.64 1.60 1.52 1.44 1.39 1.33 1.54 1.46 1.40 1.37
Peptic ulcer disease 1.48 1.47 1.41 1.41 1.22 1.20 1.20 1.19 1.28 1.27 1.26 1.25 1.23 1.21 1.21 1.23
Diabetes without complication 1.51 1.51 1.47 1.45 1.47 1.47 1.45 1.45 2.06 2.01 1.95 1.98 1.90 1.87 1.89 1.89
Diabetes with complication 1.26 1.26 1.28 1.32 1.45 1.44 1.43 1.44 3.33 3.13 3.14 3.32 2.65 2.61 2.60 2.67
Paraplegia and hemiplegia 1.96 2.01 2.13 2.10 1.52 1.52 1.57 1.56 1.35 1.39 1.33 1.44 1.25 1.24 1.32 1.41
Renal disease 3.37 3.37 3.39 3.38 2.04 2.01 2.00 1.99 1.64 1.55 1.46 1.41 2.18 2.10 2.03 2.00
Mild liver disease 3.42 3.15 2.73 2.63 2.30 2.19 2.00 1.98 1.89 1.74 1.60 1.64 1.74 1.64 1.52 1.52
Moderate and severe liver disease 6.65 5.94 6.04 5.93 2.43 2.46 2.63 2.65 1.41 2.18 1.86 2.12 2.13 2.19 2.38 2.34
Cancer 4.14 4.03 3.57 3.36 2.04 2.02 1.91 1.86 1.15 1.10 1.09 1.08 1.15 1.13 1.11 1.11
Metastatic carcinoma 16.12 14.51 13.54 12.95 4.97 4.72 4.44 4.37 1.33 1.47 1.44 1.54 1.31 1.34 1.27 1.23
AIDS/HIV 4.25 4.45 4.00 3.83 5.40 4.64 4.34 4.29 1.72 1.50 1.62 1.95 1.03 1.24 1.77 1.92
Claims and hospital abstraction data
Myocardial infarction 1.78 1.76 1.71 1.67 1.23 1.23 1.23 1.22 1.82 1.78 1.75 2.08 1.28 1.24 1.20 1.40
Congestive heart failure 3.07 2.91 2.79 2.76 2.02 1.99 1.97 1.97 2.45 2.44 2.35 2.72 2.01 2.04 2.08 2.11
Peripheral vascular disease 1.50 1.46 1.46 1.43 1.26 1.28 1.30 1.31 1.48 1.47 1.54 1.51 2.24 2.23 2.19 2.19
Cerebrovascular disease 2.55 2.39 2.26 2.14 1.51 1.48 1.45 1.42 2.02 2.03 2.00 2.17 1.23 1.23 1.19 1.28
Dementia 3.17 3.21 3.15 3.12 2.34 2.34 2.37 2.35 1.02 1.04 1.03 1.04 1.26 1.29 1.27 1.29
Chronic pulmonary disease 1.89 1.77 1.65 1.57 1.59 1.54 1.46 1.41 1.57 1.59 1.63 1.61 2.22 2.17 2.13 2.17
Connective tissue disease- rheumatic disease 1.73 1.61 1.43 1.32 1.44 1.39 1.31 1.27 1.58 1.64 1.62 1.67 2.14 2.06 2.09 2.09
Peptic ulcer disease 1.27 1.26 1.20 1.17 1.11 1.12 1.10 1.06 1.31 1.32 1.39 1.38 1.44 1.43 1.49 1.52
Diabetes without complication 1.51 1.50 1.46 1.44 1.47 1.47 1.45 1.45 2.29 2.27 2.25 2.28 2.46 2.43 2.38 2.40
Diabetes with complication 1.21 1.22 1.27 1.31 1.34 1.34 1.35 1.37 3.85 3.69 3.38 3.41 4.13 4.04 3.93 3.87
Paraplegia and hemiplegia 2.17 2.26 2.36 2.35 1.57 1.59 1.65 1.65 1.52 1.55 1.43 1.50 1.27 1.27 1.25 1.37
Renal disease 3.27 3.24 3.21 3.16 1.97 1.96 1.92 1.92 1.45 1.43 1.48 1.47 2.98 2.94 2.92 2.98
Mild liver disease 2.77 2.63 2.28 2.19 2.18 2.12 1.89 1.83 2.28 2.18 2.08 2.00 2.83 2.65 2.48 2.34
Moderate and severe liver disease 5.97 5.05 5.11 4.94 2.26 2.14 2.24 2.31 2.22 2.27 2.28 2.13 3.60 3.44 3.37 3.06
Cancer 3.19 2.87 2.49 2.32 1.85 1.76 1.63 1.59 1.13 1.13 1.11 1.10 1.52 1.47 1.39 1.34
Metastatic carcinoma 14.12 13.54 13.13 12.64 4.39 4.23 4.10 4.00 1.55 1.59 1.58 1.57 1.80 1.77 1.67 1.60
AIDS/HIV 2.83 2.97 2.18 1.95 2.82 2.60 1.77 1.67 2.35 2.55 2.75 2.96 2.29 2.58 2.69 2.91